Actively Recruiting
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Led by University Hospital, Angers · Updated on 2026-03-06
260
Participants Needed
10
Research Sites
443 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Angers
Lead Sponsor
L
Ligue contre le cancer, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prospective study to evaluate the relevance of CALR allele burden monitoring as a molecular marker of disease progression.
CONDITIONS
Official Title
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Affiliated to the national social security system
- Diagnosed with CALR mutated myeloproliferative neoplasm between 2006 and 2020
- Have at least one available sample at diagnosis or before cytoreductive treatment
- Signed consent to participate in the study
- Included or consenting to be included in the national clinical-biological database of France Intergroupe Syndrome Myéloprolifératifs (FIM)
You will not qualify if you...
- Have another active hematological disease or cancer at time of diagnosis
- Subject to a legal protection scheme or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
CHU Angers
Angers, France
Actively Recruiting
2
Chu Bordeaux
Bordeaux, France, 33604
Actively Recruiting
3
Chu Brest
Brest, France, 29200
Actively Recruiting
4
Ch Cholet
Cholet, France, 49300
Actively Recruiting
5
Ch Le Mans
Le Mans, France, 72037
Actively Recruiting
6
Ch Morlaix
Morlaix, France, 29672
Actively Recruiting
7
AP-HP Henri Mondor
Paris, France, 94010
Actively Recruiting
8
Chu Poitiers
Poitiers, France, 86021
Actively Recruiting
9
Ch Quimper
Quimper, France, 29107
Actively Recruiting
10
Chu Tours
Tours, France, 37000
Actively Recruiting
Research Team
L
Laurane COTTIN, Doctor
CONTACT
E
Emma BLANCHET
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here